Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Ampicelo 250 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Ampicelo 250

Approved

STANDARD

Ampicelo 250

Celogen Pharma Pvt. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: f0b3dc87bc4bcf04
Company: Celogen Pharma Pvt. Ltd.
Type: Standard

Approval Details

Approval Id: f0b3dc87bc4bcf04
Drug Approval Philippines Name: Ampicelo 250
Product Name: Ampicelo 250
Registration Number: DRP-5868
Brand Name: Ampicelo 250
Generic Name: Ampicillin (As Sodium)
Dosage Form: Powder For Injection (Im/Iv)
Dosage Strength: 250mg
Manufacturer: Celogen Pharma Pvt. Ltd.
Importer: Pharmastar International Trading Corp.
Distributor: Pharmastar International Trading Corp.
Issuance Date: 29 March 2023
Expiry Date: 15 July 2028
Pharmacologic Category: Antibacterial (Penicillin)
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

f0b3dc87bc4bcf04

Type

Standard

Back to Philippines FDA Approvals